The Daytona from Optos captures 200° or 82 percent of the retina in a single ultra-widefield (UWF™) optomap® image in less than half a second. The built-in eye-steering technology allows non-mydriatic, visualization and imaging of all quadrants beyond the standard 200° view,1 which can make it a valuable technology in early peripheral pathology detection, timely decision-making and, ultimately, sight preservation.
Dr. Nicole Kish has been using the Daytona in her Visionworks practice (Norman, OK) for more than a year now and has seen the value of its integration into the practice workflow protocols. With the full support of an Optos account manager, Dr. Kish has been able to incorporate her entire staff into the pre-testing process, which, in turn, reduces clinical “chair time” and increases the time spent talking with patients.2 According to Dr. Kish UWF imaging has supported her ability to identify early peripheral changes in patients suspected of having undiagnosed diabetes.
The educational value of the optomap system was a big selling point for Dr. Kish. She has been able to educate large numbers of patients about their eye conditions, providing them with “…a level of education and images of their own eyes they’ve never seen.”
Diabetic eye disease is a leading cause of blindness and vision loss,1 and, according to the World Health Organization, the incidence of diabetes worldwide is escalating.2 It is estimated that by the year 2035, the number of people worldwide with diabetes will have soared to almost 600 million.3 The National Eye Institute (NEI) reports that there are another 86 million American adults who have pre-diabetes.
Diabetic eye disease describes a group of eye conditions that include diabetic retinopathy (DR), glaucoma, diabetic macular edema and cataracts. DR is often reported as the most common form of diabetic eye disease. It is a serious complication of diabetes mellitus (DM), afflicting one third of all people with the disease, and it is the leading cause of blindness among the working population in the world.4
In its report, “Diabetic Eye Disease Projected to Increase Among U.S. Population,” the NEI states that there are currently 7.7 million people ages 40 and older who have DR, and this number is expected to increase to around 11 million by the year 2030. With advances in technology and medicine, adequate management and regular eye examinations, sight loss associated with diabetes may be prevented in 98 percent of …
Uveitis describes a group of intra-ocular inflammatory conditions, where etiology is diverse and may be characterized by inflammation of the uveal tract or indirect inflammation of adjacent tissues1. In his paper, A Long-Term Game Plan for Non-Infectious Uveitis, Sam S. Dahr, MD, reports that the majority of uveitis cases seen in daily practice are non-infectious and idiopathic in origin. This report estimates that the disease affects approximately 300,000 American adults and 22,000 American children. Of great concern for the young, is the lack of proper treatment in the early stages of the disease, which can be attributed to a poor visual outcome 2.
Proactive and effective management of non-infectious uveitis relies heavily upon developing a therapeutic strategy and a long-term plan, which may involve systemic therapy, patient counseling, close follow-up, dosing adjustments, combination therapy, and consultation with rheumatologists. In his report, however, Sam S. Dahr, MD, suggests that imaging metrics are “…more powerful than any blood test the rheumatologist can order to monitor response”; positioning ophthalmologists to “… bear the decision-making responsibility for these patients.” Many patients with non-infectious uveitis suffer “…inflammatory breakthroughs during systemic therapy, most of which tend to be fairly mild and treatable with topical, injected or …
A survey conducted by the American Academy of Ophthalmology (AAO) highlighted a significant discrepancy between the perceived versus the actual danger of the home environment being a threat for eye injuries1. The survey determined that fewer than half of the respondents saw the home environment as a potential site for eye injuries, and those that did cited the garden and garage as the most dangerous places. In reality, however, each year it is estimated that 50 percent of all eye injuries occur in the home and most could have been prevented if proper eye protection had been worn2. Sadly, only 35 percent of people surveyed claimed to follow a practice of home eye safety by always wearing eye protection when it was needed.
Statistics show that there are several ways that people are at risk of eye injury in their homes. The AAO reported that 125,000 eye injuries occur each year due to accidents involving common household products, such as bleach and oven cleaner. Unprotected eyes are also at risk where there are things that move at high speed, such as debris from yard work, power tools or nails being hammered into hard surfaces and even champagne corks.
Athletes of all levels need to protect themselves from injury. Injuries are unfortunately a part of playing sports – anyone from weekend warriors to professionals, has probably nursed some sort of injury. In some cases, these injuries happen directly to the eye, from orbital blowout fracture, ruptured globe, or a detached retina and some can be detected, along with other types of ocular and systemic pathology, by looking at the health of the eye.
There have been, and continue to be, many studies in the area of sports-related eye trauma. And with more and more interest in the effects of concussions on athletes, seeing “inside” the eye is becoming increasingly important. An x-ray, MRI, CT scan will tell you if something is broken and may confirm a diagnosis of concussion. But what about the effects of repetitive concussive injury? Can that be detected by imaging the eye itself? According to the Centers for Disease Control, up to 3.8 million sports-related concussions occur each year. And detecting these injuries is not always straightforward or based exclusively on objective signs and symptoms. Or what about treating the whole athlete and monitoring systemic as well as ocular health?